These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7480201)

  • 1. Inhibitors of DNA topoisomerase I and II isolated from the Coptis rhizomes.
    Kobayashi Y; Yamashita Y; Fujii N; Takaboshi K; Kawakami T; Kawamura M; Mizukami T; Nakano H
    Planta Med; 1995 Oct; 61(5):414-8. PubMed ID: 7480201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of topoisomerase II-mediated DNA cleavage by a protoberberine alkaloid, berberrubine.
    Kim SA; Kwon Y; Kim JH; Muller MT; Chung IK
    Biochemistry; 1998 Nov; 37(46):16316-24. PubMed ID: 9819224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of DNA topoisomerase I by natural and synthetic mono- and dimeric protoberberine alkaloids.
    Qin Y; Pang JY; Chen WH; Zhao ZZ; Liu L; Jiang ZH
    Chem Biodivers; 2007 Mar; 4(3):481-7. PubMed ID: 17372950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA topoisomerase I inhibitory alkaloids from Corydalis saxicola.
    Cheng X; Wang D; Jiang L; Yang D
    Chem Biodivers; 2008 Jul; 5(7):1335-44. PubMed ID: 18649321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of topoisomerase I function by coralyne and 5,6-dihydrocoralyne.
    Wang LK; Rogers BD; Hecht SM
    Chem Res Toxicol; 1996; 9(1):75-83. PubMed ID: 8924619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of topoisomerase II-mediated DNA cleavage by three DNA-intercalating plant alkaloids: cryptolepine, matadine, and serpentine.
    Dassonneville L; Bonjean K; De Pauw-Gillet MC; Colson P; Houssier C; Quetin-Leclercq J; Angenot L; Bailly C
    Biochemistry; 1999 Jun; 38(24):7719-26. PubMed ID: 10387011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cationic porphyrins and analogues as new DNA topoisomerase I and II inhibitors.
    Shuai L; Wang S; Zhang L; Fu B; Zhou X
    Chem Biodivers; 2009 Jun; 6(6):827-37. PubMed ID: 19551725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA topoisomerase I inhibitors from Rinorea anguifera.
    Ma J; Jones SH; Marshall R; Wu X; Hecht SM
    Bioorg Med Chem Lett; 2005 Feb; 15(3):813-6. PubMed ID: 15664863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory activities of the alkaloids from Coptidis Rhizoma against aldose reductase.
    Jung HA; Yoon NY; Bae HJ; Min BS; Choi JS
    Arch Pharm Res; 2008 Nov; 31(11):1405-12. PubMed ID: 19023536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luotonin A. A naturally occurring human DNA topoisomerase I poison.
    Cagir A; Jones SH; Gao R; Eisenhauer BM; Hecht SM
    J Am Chem Soc; 2003 Nov; 125(45):13628-9. PubMed ID: 14599178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minor groove-directed and intercalative ligand-DNA interactions in the poisoning of human DNA topoisomerase I by protoberberine analogs.
    Pilch DS; Yu C; Makhey D; LaVoie EJ; Srinivasan AR; Olson WK; Sauers RR; Breslauer KJ; Geacintov NE; Liu LF
    Biochemistry; 1997 Oct; 36(41):12542-53. PubMed ID: 9376359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine oxidase inhibitors from rhizoma of Coptis chinensis.
    Kong LD; Cheng CH; Tan RX
    Planta Med; 2001 Feb; 67(1):74-6. PubMed ID: 11270727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II.
    Wassermann K; Markovits J; Jaxel C; Capranico G; Kohn KW; Pommier Y
    Mol Pharmacol; 1990 Jul; 38(1):38-45. PubMed ID: 2164630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of topoisomerase I as the cytotoxic target of the protoberberine alkaloid coralyne.
    Gatto B; Sanders MM; Yu C; Wu HY; Makhey D; LaVoie EJ; Liu LF
    Cancer Res; 1996 Jun; 56(12):2795-800. PubMed ID: 8665516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Poisons of DNA topoisomerases I and II].
    Charcosset JY; Soues S; Laval F
    Bull Cancer; 1993 Nov; 80(11):923-54. PubMed ID: 8081034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel quinazoline-quinoline alkaloids with cytotoxic and DNA topoisomerase II inhibitory activities.
    Ma Z; Hano Y; Nomura T; Chen Y
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1193-6. PubMed ID: 14980663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory activities against topoisomerase I and II by isoaurostatin derivatives and their structure-activity relationships.
    Suzuki K; Okawara T; Higashijima T; Yokomizo K; Mizushima T; Otsuka M
    Bioorg Med Chem Lett; 2005 Apr; 15(8):2065-8. PubMed ID: 15808469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding topoisomerase I and II in terms of QSAR.
    Verma RP
    Bioorg Med Chem; 2005 Feb; 13(4):1059-67. PubMed ID: 15670914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinesterase inhibitory alkaloids from the rhizomes of Coptis chinensis.
    Cao TQ; Ngo QT; Seong SH; Youn UJ; Kim JA; Kim J; Kim JC; Woo MH; Choi JS; Min BS
    Bioorg Chem; 2018 Apr; 77():625-632. PubMed ID: 29502023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA-topoisomerase inhibitors.
    D'Incalci M
    Curr Opin Oncol; 1993 Nov; 5(6):1023-8. PubMed ID: 8305535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.